Arbutus Biopharma (ABUS) Tops Q3 EPS by 20c

Arbutus Biopharma (NASDAQ: ABUS) reported Q3 EPS of ($0.17), $0.20 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.

You May Also Be Interested In

• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance